Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CKS1B | P61024 | 13/20 | 0.41 |
| ▸ | SKP1 | P63208 | 13/20 | 0.41 |
| ▸ | SKP2 | Q13309 | 13/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8215295 | 0.89 | CHRM4 (0.45) | CKS1BSKP1SKP2 | |
| SCHEMBL8273638 | 0.88 | ALDH1A1 (0.38) | CKS1BSKP1SKP2NPC1MAPK1 | |
| SCHEMBL8273635 | 0.88 | CKS1B (0.37) | CKS1BSKP1SKP2TSHRALDH1A1 | |
| SCHEMBL8273640 | 0.87 | ALDH1A1 (0.38) | CKS1BSKP1SKP2NPC1MAPK1 | |
| SCHEMBL8275485 | 0.84 | CKS1B (0.39) | CKS1BSKP1SKP2RAB9ASMN1; SMN2 | |
| SCHEMBL8273636 | 0.84 | ALDH1A1 (0.39) | CKS1BSKP1SKP2NPC1RAB9A | |
| SCHEMBL8275481 | 0.83 | PIK3CB (0.43) | CKS1BSKP1SKP2SMN1; SMN2TSHR | |
| SCHEMBL8276134 | 0.80 | ADAM17 (0.37) | CKS1BSKP1SKP2TSHRALDH1A1 | |
| SCHEMBL8273643 | 0.80 | ALDH1A1 (0.38) | CKS1BSKP1SKP2NPC1RAB9A | |
| SCHEMBL8275791 | 0.80 | KDM4E (0.34) | CKS1BSKP1SKP2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005121130-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |